CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Xenetic Biosciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Xenetic Biosciences Inc
40 Speen St Ste 102
Phone: (781) 778-7720p:781 778-7720 FRAMINGHAM, MA  01701-1898  United States Ticker: XBIOXBIO

Business Summary
Xenetic Biosciences, Inc. is a biopharmaceutical company. The Company is focused on progressing XCART, a personalized chimeric antigen receptor (CAR) T platform technology engineered to target patient-specific tumor neoantigens. The Company is advancing cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. The Company is leveraging PolyXen, its drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen enables biological drugs by modifying their half-life and other pharmacological properties.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202012/31/2019YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Chief Operating Officer, Director Jeffrey F.Eisenberg 53 10/26/2017 7/8/2016
Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer James F.Parslow 52 4/24/2017 4/3/2017
Chief Scientific Officer Curtis A.Lockshin 56 1/1/2017 1/1/2017
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Xenetic Biosciences PLC Greener House, 66-68 Haymarket LONDON ENG United Kingdom

Business Names
Business Name
General Aircraft, Inc.
General Sales & Leasing Inc
Hesperix S.A.
8 additional Business Names available in full report.

General Information
Number of Employees: 4 (As of 12/31/2019)
Outstanding Shares: 8,745,207 (As of 12/10/2020)
Shareholders: 425
Stock Exchange: NASD
Federal Tax Id: 452952962


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 8, 2021